Rebuttable Presumption for Certain Deaths:
HB 1611 creates a new section of Florida Statutes establishing a rebuttable presumption in favor of the defense in certain homicide cases. The presumption applies when a defendant is charged with second-degree murder or manslaughter and a forensic toxicology report shows that a Schedule I controlled substance was present in the alleged victim at the time of death. In those circumstances, the bill presumes that the death was the result of the controlled substance rather than the defendant’s conduct, unless the presumption is rebutted by other evidence.
The bill is narrowly targeted to criminal cases involving deaths where illegal drugs are found in the victim’s system. It would affect how prosecutors and defense attorneys litigate causation in murder and manslaughter cases, potentially making it harder for the state to prove that the defendant caused the death when a Schedule I drug is present. The act would take effect July 1, 2025, but according to the bill history it died in the Criminal Justice Subcommittee and did not advance further.
HB 1611 would add a new evidentiary rule to Florida criminal law by creating a statutory rebuttable presumption tied to causation in second-degree murder and manslaughter prosecutions. It would not change the elements of those offenses directly, but it would shift the litigation posture in cases where toxicology shows a Schedule I controlled substance in the decedent’s body, giving the defense a statutory basis to argue the drug, rather than the defendant’s conduct, caused the death. The practical effect would be on prosecutors, defense counsel, courts, and forensic evidence in homicide cases involving illegal drugs.
The available bill history suggests the measure did not receive enough support to move out of the Criminal Justice Subcommittee, as it died there without recorded votes or committee debate in the provided materials. Because no transcripts or vote tallies are included, there is no detailed record of floor or committee sentiment, but the lack of advancement indicates limited legislative momentum. The bill’s framing suggests it was intended to help defendants in drug-involved death cases, which may have contributed to concern among lawmakers focused on homicide accountability and prosecutorial burden.
The main point of contention is likely the bill’s shift in causation analysis in serious felony cases. Supporters would favor the presumption as a safeguard where a victim’s illegal drug use may have contributed to death, while opponents may view it as an unwarranted advantage for defendants that could complicate murder and manslaughter prosecutions. Another likely issue is the bill’s narrow trigger: it applies only when a Schedule I controlled substance appears in toxicology results, raising questions about whether the presumption is too broad, too narrow, or scientifically difficult to apply in mixed-cause deaths. No specific speakers or recorded objections are provided in the materials.